-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Markets Affirms Carl Zeiss Meditec's Sector Perform Rating

MT Newswires·12/24/2025 07:18:02
Listen to the news
07:18 AM EST, 12/24/2025 (MT Newswires) -- RBC Capital Markets on Tuesday reiterated medical technology company Carl Zeiss Meditec's (AFX.F) sector perform rating and kept its price target at 47.00 euros. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)